October 28, 2021

Volume XI, Number 301

Advertisement
Advertisement

October 27, 2021

Subscribe to Latest Legal News and Analysis

October 26, 2021

Subscribe to Latest Legal News and Analysis

October 25, 2021

Subscribe to Latest Legal News and Analysis
Advertisement

Nota Bene Episode 78: COVID-19 and Other Change Agents to the Healthcare Industry Outlook for 2020 with Mike McKinnon

Healthcare systems in the U.S. are feeling the stress of COVID-19. In an attempt to respond to the unexpected impact of the virus on the healthcare industry, the government along with private industry have implemented various measures to help weather the changes while continuing to serve the needs of patients. We’re taking a closer look at what changes have been implemented thus far and forecasting policy changes going forward.

Joining Michael Cohen for this conversation is Michael McKinnon. Mike is a partner in the Corporate Practice Group in the Sheppard Mullin Orange County office. Michael is leader of the firm's Healthcare Private Equity Team. Michael focuses his practice on corporate and securities law, with an emphasis on mergers and acquisitions, joint ventures, and equity and debt financings in the healthcare and life sciences industries.

What We Discuss in This Episode

  • How will COVID-19 affect the healthcare industry going forward?

  • What is the immediate impact of COVID-19 on healthcare providers?

  • What is the Coronavirus Preparedness and Response Supplemental Appropriations Act?

  • What did the Families First Coronavirus Response Act provide for healthcare providers?

  • How has the government loosened certain restrictions when it comes to where medical procedures can take place?

  • Will there be greater collaboration between the government and private industry due to the pandemic?

  • Along with telemedicine, what other advancements in technologies will be utilized going forward?

  • Why a multi-billion dollar grant from the government to hospitals is not likely to alleviate the financial stress

  • Will there be a long-term shift in where medical procedures are performed?

Resources: 

Copyright © 2021, Sheppard Mullin Richter & Hampton LLP.National Law Review, Volume X, Number 113
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

 Michael P.A. Cohen Partner DC Antitrust and Competition
Partner

Michael is a partner with the Antitrust and International Competition Practice Group in the firm's Washington, D.C. office.

Areas of Practice

Michael began his career as an Assistant Special Prosecutor, investigating and prosecuting organized crime involvement with the failure of local financial institutions in the early 1990s. After his government service, Michael joined the historic Washington, D.C. antitrust firm Howrey & Simon, where in 1996, he became one of the youngest partners in that unique firm’s history. In 2003, Michael joined Heller Ehrman as...

202-747-1958
Michael G. McKinnon, Sheppard Mullin, joint ventures lawyer, equity debt financings attorney
Partner

Michael McKinnon is a partner in the Corporate Practice Group in the firm's Orange County office.

Mr. McKinnon focuses his practice on corporate and securities law, with an emphasis on mergers and acquisitions, joint ventures, and equity and debt financings in the healthcare and life sciences industries. He has assisted clients in acquiring or investing in medical device companies, home infusion providers, diagnostic imaging providers, medical groups, physician practices, surgery centers, PPO networks, diabetic supply businesses, clinical trial...

714.424.2867
Advertisement
Advertisement
Advertisement